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1 |  INTRODUCTION
The developing sympathetic nervous system is a well-es-
tablished model for understanding how neuron survival 
and axon growth are regulated and how tissue innervation 
is established and modified. Several extracellular signals 
control the establishment of sympathetic innervation in the 
developing peripheral nervous system by regulating neuronal 
survival and controlling the growth and ramification of axons 
within innervated tissues (Davies, 2009; Glebova & Ginty, 
2005). The best characterized of these is the secreted protein 
nerve growth factor (NGF), which is synthesized in target tis-
sues. NGF promotes the survival of developing sympathetic 
neurons and the level of NGF synthesis in different tissues 
regulates the number of neurons that innervate these tissues 
(Crowley et al., 1994; Davies, 2003). NGF also promotes the 
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Abstract
CD40-activated CD40L reverse signaling is a major physiological regulator of the 
growth of neural processes in the developing nervous system. Previous work on su-
perior cervical ganglion (SCG) neurons of the paravertebral sympathetic chain has 
shown that CD40L reverse signaling enhances NGF-promoted axon growth and tis-
sue innervation. Here we show that CD40L reverse signaling has the opposite func-
tion in prevertebral ganglion (PVG) sympathetic neurons. During a circumscribed 
perinatal window of development, PVG neurons cultured from Cd40–/– mice had 
substantially larger, more exuberant axon arbors in the presence of NGF than PVG 
neurons cultured from wild-type mice. Tissues that receive their sympathetic inner-
vation from PVG neurons were markedly hyperinnervated in Cd40–/– mice compared 
with wild-type mice. The exuberant axonal growth phenotype of cultured CD40-
deficient perinatal PVG neurons was pared back to wild-type levels by activating 
CD40L reverse signaling with a CD40-Fc chimeric protein, but not by activating 
CD40 forward signaling with CD40L. The co-expression of CD40 and CD40L in 
PVG neurons suggests that these proteins engage in an autocrine signaling loop in 
these neurons. Our work shows that CD40L reverse signaling is a physiological regu-
lator of NGF-promoted sympathetic axon growth and tissue innervation with oppo-
site effects in paravertebral and prevertebral neurons.
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growth and branching of sympathetic axons within their tar-
get tissues (Glebova & Ginty, 2004).
Several members of the tumor necrosis factor superfamily 
(TNFSF) have recently been shown to be key physiological 
regulators of NGF-promoted sympathetic axon growth and 
tissue innervation in development without affecting neuro-
nal survival. Members of the TNFSF bind to one or more 
members of the TNF receptor superfamily (TNFRSF) and 
are active both as membrane-integrated ligands and as sol-
uble ligands following cleavage from the cell membrane 
(Grivenniko, Kuprash, Liu, & Nedospasov, 2006; Hehlgans 
& Pfeffer, 2005). In addition, several TNFRSF members 
can also act as ligands for the membrane-integrated TNFSF 
to which they bind, which function as reverse signaling re-
ceptors (Sun & Fink, 2007). While the TNF and TNFR su-
perfamilies are best understood for their many roles in the 
immune system (Hehlgans & Pfeffer, 2005; Sedy, Bekiaris, 
& Ware, 2014), several members of these superfamilies mod-
ulate NGF-promoted sympathetic axon growth by forward 
and reverse signaling mechanisms. NGF-promoted sympa-
thetic axon growth and tissue innervation are suppressed by 
TNF-activated TNFR1-mediated forward signaling (Erice, 
Calhan, Kisiswa, Wyatt, & Davies, 2019; Gutierrez et al., 
2013) and by BCMA-activated TWE-PRIL-mediated re-
verse signaling (Howard et al., 2018). NGF-promoted sym-
pathetic axon growth and tissue innervation are enhanced by 
TNFR1-activated TNF-mediated reverse signaling (Kisiswa 
et al., 2013, 2017) and by CD40-activated CD40L-mediated 
reverse signaling (McWilliams, Howard, Wyatt, & Davies, 
2015). GITRL/GITR signaling also enhances NGF-promoted 
axon growth and tissue innervation (O'Keeffe, Gutierrez, 
Pandolfi, Riccardi, & Davies, 2008), although the direction 
of signaling, forward or reverse, has yet to be investigated.
CD40–CD40L bidirectional signaling, the focus of the 
current study, is of increasing interest. Not only does it play a 
physiological role in regulating sympathetic and sensory axon 
growth in the developing PNS (Howard, McWilliams, Wyatt, 
& Davies, 2019; McWilliams et al., 2015), it plays a key role in 
regulating axon and dendrite growth from several different kinds 
of neurons in the developing CNS (Carriba & Davies, 2017). In 
the immune system, CD40–CD40L signaling plays several key 
roles in regulating immune responses, CD40–CD40L signaling 
has been implicated in the pathogenesis of autoimmune disor-
ders (Peters, Stunz, & Bishop, 2009) and there is increasing 
interest in the relevance of CD40–CD40L signaling for can-
cer immunotherapy (Richards, Sefrin, Gieffers, Hill, & Merz, 
2019). This emphasizes the need to understand the biology of 
CD40–CD40L signaling in greater detail.
Virtually, all work on sympathetic axon growth and tissue 
innervation has been done on the easily accessible neurons 
of the superior cervical ganglion (SCG) of the paravertebral 
sympathetic chain and their cranial innervation targets. Here, 
we have studied the sympathetic neurons of prevertebral 
ganglia (PVG) and the visceral tissues they innervate. We 
find that CD40-activated CD40L-mediated reverse signaling 
is a physiologically important regulator of PVG axon growth 
and PVG target innervation, but with diametrically opposite 
functions to those observed on SCG axons and SCG target 
innervation. Our findings demonstrate how CD40L reverse 
signaling displays distinctive functions in the development of 
different populations of the same class of neurons.
2 |  RESULTS
2.1 | PVG and SCG neurons co-express 
CD40 and CD40L
We have previously reported that the majority of developing 
SCG neurons co-express CD40 and CD40L (McWilliams et al., 
2015). We used immunocytochemistry to determine whether 
PVG neurons also express these glycoproteins and whether 
they are co-expressed. Anti-CD40 (Figure 1a) and anti-CD40L 
(Figure 1b) antibodies each labeled the great majority of neu-
rons positively identified by double-labeling with anti-βIII tu-
bulin in dissociated cultures of P0 PVG neurons of the coeliac 
and superior mesenteric ganglia (90.32 ± 1.46% tubulin-posi-
tive neurons were CD40-positive and 92.34 ± 1.12% tubulin-
positive neurons were CD40L-positive). For comparison, P0 
SCG neuron cultures were set up in parallel and were labeled 
with anti-CD40 (Figure 1c) and anti-CD40L (Figure 1d) anti-
bodies. Very similar labeling was observed for both antibodies 
(89.18 ± 2.91% tubulin-positive neurons were CD40-positive 
and 85.84  ±  2.40% tubulin-positive neurons were CD40L-
positive), as previously reported (McWilliams et al., 2015). 
All of the neurons in both sets of cultures were also stained 
with anti-tyrosine hydroxylase (TH), demonstrating that these 
were sympathetic neurons, as expected (not shown). No cells 
were labeled when primary antibodies were omitted and la-
beling with anti-CD40 was eliminated in cultures established 
from Cd40–/– mice (not shown). These observations suggest 
that the great majority of PVG neurons co-express CD40 and 
CD40L at the stage when sympathetic axons are innervating 
their targets during the peak of responsiveness to CD40L re-
verse signaling (see below).
2.2 | CD40–CD40L signaling has opposing 
effects on NGF-promoted axon growth from 
PVG and SCG neurons
The co-expression of CD40 and CD40L by PVG neurons 
raised the possibility of autocrine signaling. We have previ-
ously shown that CD40–CD40L autocrine signaling in SCG 
neurons enhances NGF-promoted axon growth (McWilliams 
et al., 2015). To ascertain how CD40L autocrine signaling 
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might influence PVG neuron development, we compared 
axon growth from cultures of dissociated PVG neurons es-
tablished from Cd40+/+ and Cd40–/– newborn mice. We 
reasoned that the absence of CD40 would eliminate any po-
tential CD40–CD40L signaling loop and reveal its role.
To our surprise, in the presence of NGF, PVG neurons 
cultured from Cd40–/– newborn mice exhibited significantly 
longer and significantly more branched axon arbors than PVG 
neurons cultured from Cd40+/+ littermates (Figure 2a,b). The 
Sholl plots for these cultures are shown in Figure 2c and rep-
resentative images are shown in Figure 2d.
Because this difference in axon growth from CD40-
deficient and wild-type PVG neuron was the very opposite 
of what we had reported for SCG neurons cultured from 
Cd40+/+ and Cd40–/– mice (McWilliams et al., 2015), we 
established dissociated cultures of PVG and SCG neurons 
in parallel. The SCG neuron cultures replicated our reported 
findings and showed that CD40-deficient SCG neurons had 
shorter, less exuberant axon arbors than wild-type SCG neu-
rons (Figure 2e–h). These detailed comparative studies were 
undertaken on P0 neurons using 1  ng/ml of NGF because 
these are the age and NGF concentration at which the effects 
of CD40/CD40L signaling on axon growth are maximal in 
both the populations of sympathetic neurons (Figures 3 and 4). 
Taken together, these results suggest that CD40–CD40L sig-
naling has opposite effects on NGF-promoted axon growth 
from neonatal PVG and SCG neurons.
2.3 | CD40–CD40L signaling modulates 
NGF-promoted axon growth over the 
same developmental window in PVG and 
SCG neurons
We have reported that the effect of CD40–CD40L signal-
ing on NGF-promoted axon growth from SCG neurons is 
F I G U R E  1  PVG and SCG neurons co-express CD40 and CD40L. Representative images of P0 PVG neurons (a,b) and SCG neurons (c,d) 
cultured for 24 hr in medium containing 1 ng/ml of NGF and double labeled for either anti-CD40 and anti-βIII tubulin (a,c) or anti-CD40L and 
anti-βIII tubulin (b,d). The preparations were also counterstained with the nuclear marker DAPI. Scale bar, 10 μm
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restricted to a developmental window and is maximal at 
P0 several days after the neurons have become depend-
ent on NGF for survival when SCG axons are ramifying 
extensively in their targets (McWilliams et al., 2015). To 
explore the possibility that the effect of CD40–CD40L sign-
aling on NGF-promoted axon growth is also restricted to 
a developmental window in PVG neurons, we established 
dissociated PVG cultures from Cd40–/– mice and Cd40+/+ 
littermates over a range of different ages. The difference 
in NGF-promoted axon growth between PVG neurons of 
Cd40–/– mice and PVG neurons of Cd40+/+ littermates was 
also observed during a clear developmental window. For 
direct comparison with SCG neurons, we set up cultures 
of PVG neurons and SCG neurons at the same ages (E18, 
P0, P3, and P5). For both kinds of neurons, the differences 
in axon length between CD40-deficient and wild-type neu-
rons were maximal in cultures established at P0 (Figure 3). 
Smaller, statistically significant differences in axon length 
between CD40-deficient and wild-type neurons were ob-
served in both PVG and SCG neuron cultures established 
F I G U R E  2  CD40–CD40L signaling has opposing effects on NGF-promoted axon growth from PVG and SCG neurons. Total axon length 
(a,e), branch point number (b,f), Sholl plots (c,g) and representative images (d,h) of the neurite arbors of PVG (a–d), and SCG (e–h) neurons of 
P0 Cd40+/+ and Cd40–/– littermates grown for 24 hr with 1 ng/ml of NGF. Mean ± SEM data of >150 neurons per condition combined from three 
experiments of each type. Scale bar, 50 μm. ***p < .001, *p < .05 (the differences between both length and branch points of Cd40+/+ and Cd40–/– 
PVG and SCG neurons were analyzed by Mann–Whitney test)
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at E18 (Figure 3a,e) and at P3 (Figure 3c,g). There were no 
statistically significant differences in axon length between 
CD40-deficient and wild-type neurons in both P5 PVG and 
P5 SCG cultures (Figure 3d,h). These data suggest that the 
regulation of NGF-promoted axon growth by CD40–CD40L 
signaling operates over very similar perinatal developmental 
windows in both PVG and SCG neurons.
2.4 | NGF concentration dependence of 
axon growth modulation by CD40–CD40L 
signaling in PVG and SCG neurons
Another key feature of the effect of CD40–CD40L signaling 
on NGF-promoted axon growth from SCG neurons is that it 
was only observed over a narrow NGF concentration range 
F I G U R E  3  CD40–CD40L signaling 
modulates NGF-promoted axon growth 
over the same developmental window in 
PVG and SCG neurons. Sholl plots PVG 
(a–d) and SCG (e–h) neurons at E18 (a,e), 
P0 (b,f), P3 (c,g) and P5 (d,h) Cd40+/+ and 
Cd40–/– littermates grown for 24 hr with 
1 ng/ml of NGF. The insets show bar charts 
of axon length for each age. Mean ± SEM 
data of >150 neurons per condition 
combined from three experiments of each 
type. ***p < .001, *p < .05 (the differences 
between both length and branch points of 
Cd40+/+ and Cd40–/– PVG and SCG neurons 
were analyzed by Mann–Whitney test)
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between 0.01 and 1 ng/ml of NGF (McWilliams et al., 2015). 
To ascertain whether the effect of CD40–CD40L signaling 
on NGF-promoted axon growth from PVG neurons is also 
NGF concentration-dependent, we established cultures of 
PVG and SCG neurons in parallel from P0 Cd40–/– mice and 
Cd40+/+ littermates and incubated them with different NGF 
concentrations. All cultures received the broad-spectrum cas-
pase inhibitor Boc-D-FMK to prevent apoptosis in the ab-
sence of NGF or with low levels of NGF. The great majority 
of neurons survived in these experiments and there were no 
significant differences in survival between the experimental 
groups (not shown).
Differences in axon length and branching between PVG neu-
rons of Cd40–/– and Cd40+/+ mice were NGF concentration-de-
pendent. No statistically significant differences in axon length 
and branching were observed in the absence of NGF and with 
the lowest concentration of NGF used (0.01 ng/ml). Statistically 
significant differences in axon length (Figure 4a) and branching 
(Figure 4b) between CD40-deficient and wild-type PVG neu-
rons were evident in the presence of higher NGF concentrations 
(0.1, 1, and 10  ng/ml, the highest NGF concentration used). 
The NGF concentration-dependence of axonal growth from 
CD40-deficient and wild-type SCG neurons previously re-
ported (McWilliams et al., 2015) was repeated here. However, 
F I G U R E  4  NGF concentration 
dependence of axon growth modulation 
by CD40–CD40L signaling in PVG and 
SCG neurons. Bar charts of total axon 
length (a,d) and branch point number (b,e) 
and Sholl plots (c,f) of the neurite arbors 
of PVG (a–c) and SCG (d–f) neurons 
of P0 Cd40+/+ and Cd40–/– littermates 
grown for 24 hr with either no NGF or the 
different concentrations of NGF indicated. 
All cultures received 25 mM Boc-D-
FMK to prevent apoptosis with no or low 
concentrations of NGF. Mean ± SEM data 
of >150 neurons per condition combined 
from three experiments of each type. 
***p < .001, **p < .01, *p < .05. The 
differences between both length and branch 
points of Cd40+/+ and Cd40–/– PVG and 
SCG neurons at each of NGF concentration 
points were analyzed by the Mann–Whitney 
test
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statistically significant differences were observed over a range 
of lower NGF concentrations compared with PVG neurons. No 
statistically significant differences in axon length and branching 
were observed in the absence of NGF and at the highest con-
centration used (10 ng/ml). Statistically significant differences 
in axon length (Figure 4d) and branching (Figure 4e) between 
CD40-deficient and wild-type SCG neurons were evident in 
cultures supplemented with a range of lower NGF concentra-
tions (0.01, 0.1, and 1 ng/ml). The NGF concentration-depen-
dency of axon growth from CD40-deficient and wild-type PVG 
and SCG neurons is further illustrated by the Sholl plots for 
these experiments (Figure 4c,f). Taken together, these results 
suggest that axon growth differences between CD40-deficient 
and wild-type neurons are NGF concentration-dependent for 
both PVG and SCG neurons, but the NGF concentration was 
shifted upward by an order of magnitude for PVG neurons.
2.5 | Regulation of Cd40 mRNA expression 
in PVG and SCG neurons by NGF
The lack of effect of Cd40 deletion on axon growth from 
SCG neurons at a high NGF concentration has been shown to 
be due to a marked negative regulation of Cd40 mRNA ex-
pression by NGF in these neurons (McWilliams et al., 2015). 
To ascertain whether NGF regulates the expression of Cd40 
mRNA in PVG neurons and to compare with the effect of 
NGF on the expression of Cd40 mRNA in SCG neurons, we 
cultured both kinds of neurons at P0 with and without 10 ng/
ml of NGF. To ensure similar survival in both culture condi-
tions, all cultures received Boc-D-FMK. The measurement 
of Cd40 mRNA by RT-qPCR after 24 hr showed that NGF 
caused a very marked 25-fold reduction of Cd40 mRNA in 
SCG cultures but only a 2-fold reduction in PVG cultures 
(Figure 5). This suggests that NGF negatively regulates the 
expression of Cd40 mRNA in both kinds of neurons, but that 
SCG neurons are substantially more sensitive to negative 
regulation by NGF than PVG neurons.
2.6 | Modulation of NGF-promoted axon 
growth from PVG and SCG neurons by a 
CD40L reverse signaling mechanism
Interaction between CD40L and CD40 can initiate bidirec-
tional signaling: CD40L-activated CD40-mediated forward 
signaling and CD40-activated CD40L-mediated reverse 
signaling (Sun & Fink, 2007). In vitro phenotype rescue ex-
periments have demonstrated that CD40L reverse signaling 
mediates enhanced NGF-promoted axon growth from SCG 
neurons (McWilliams et al., 2015). To ascertain whether 
either CD40 forward signaling or CD40L reverse signaling 
mediates suppression of NGF-promoted axon growth from 
PVG neurons, we established NGF-supplemented PVG neu-
ron cultures from P0 Cd40+/+ and Cd40–/– littermates. The 
aim was to ascertain whether CD40L or CD40-Fc chimera 
(in which the extracellular domain of CD40 is linked to the 
Fc part of human IgG1) that activates CD40L-mediated re-
verse signaling (Carriba & Davies, 2017; McWilliams et al., 
2015) could rescue the exuberant axon phenotype of CD40-
deficient PVG neurons. As a control, NGF-supplemented 
SCG cultures from P0 Cd40+/+ and Cd40–/– littermates were 
set up in parallel and were treated with CD40L and CD40-Fc. 
Compared with wild-type neurons, the axon arbors of CD40-
deficient PVG and CD40-deficient SCG neurons were signif-
icantly larger and smaller, respectively, than the axon arbors 
of wild-type neurons (Figure 6a,b). In both PVG and SCG 
neurons, these phenotypic changes were pared back to wild-
type levels by CD40-Fc but not by CD40L. These results sug-
gest that the contrasting effects of CD40–CD40L signaling 
on NGF-promoted axon growth from PVG and SCG neurons 
are mediated by reverse signaling in both kinds of neurons.
2.7 | Hyperinnervation of PVG 
target organs in mice with a null mutation 
in the Cd40 gene
To ascertain the physiological significance of our in vitro ob-
servations, we used immunolabeling-enabled three-dimen-
sional imaging of solvent-cleared organs (iDISCO) (Renier 
et al., 2014) to visualize and compare the innervation of 
selected organs in Cd40–/–, Cd40±, and Cd40+/+ littermates 
that were generated by crossing Cd40± mice. Axons were la-
beled using an antibody against tyrosine hydroxylase (TH), a 
rate-limiting enzyme in the biosynthesis of noradrenaline, a 
marker for sympathetic fibers. We examined three organs that 
receive their sympathetic innervation predominantly from 
PVG neurons in rodents, the stomach, spleen, and kidney. 
F I G U R E  5  Regulation of Cd40 mRNA expression in PVG 
and SCG neurons by NGF. Bar chart of the levels of Cd40 mRNA 
relative to reference mRNAs in wild-type cultures of P0 PVG and SCG 
neurons cultured for 24 hr with and without 10 ng/ml of NGF. The data 
are normalized to a value of 1.0 for PVG neurons and for SCG neurons 
cultured without NGF. All cultures received 25 mM Boc-D-FMK. 
Mean ± SEM of data from three separate experiments
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The stomach receives its sympathetic innervation predomi-
nantly from the coeliac and superior mesenteric ganglia and 
has smaller contributions from the splanchnic ganglia and the 
lower thoracic paravertebral sympathetic chain. The spleen 
receives its sympathetic innervation predominantly from the 
splanchnic ganglia and coeliac ganglion and has smaller con-
tributions from the inferior mesenteric ganglion and lower 
thoracic paravertebral sympathetic chain. Most of the sympa-
thetic neurons that innervate the kidney are located in the coe-
liac ganglion (Chevendra & Weaver, 1991; Gattone, Marfurt, 
& Dallie, 1986; Quinson, Robbins, Clark, & Furness, 2001; 
Trudrung, Furness, Pompolo, & Messenger, 1994).
Although the great majority of TH-positive fibers in 
abdominal organs originate from sympathetic ganglia, the 
nodose ganglion, which contributes to the sensory innerva-
tion of abdominal and thoracic viscera, does contain a small 
subset of TH-positive neurons in rodents (Katz, Markey, 
Goldstein, & Black, 1983; Zhuo, Ichikawa, & Helke, 1997) 
and some TH-positive nodose fibers have been convincingly 
demonstrated in at least the stomach (Kummer, Bachmann, 
Neuhuber, Hanze, & Lang, 1993). Because of this, any ef-
fect of CD40/CD40L signaling on axon growth and branch-
ing from nodose neurons could potentially interfere to some 
extent with our in vivo analysis. Notwithstanding the small 
number of TH-positive nodose fibers involved, we carried 
out experiments on dissociated nodose ganglion neurons cul-
tured from Cd40+/+ and Cd40–/– mice. Because the great ma-
jority of mouse nodose ganglion neurons depend on BDNF 
for survival and because nodose neurons have an earlier de-
velopmental profile than sympathetic neurons (Davies, Lee, 
& Jaenisch, 1993), the responses of late fetal nodose neu-
rons to a broad range of BDNF concentrations (0.01 to 10 ng/
ml) were analyzed. However, the BDNF dose responses 
of Cd40+/+ and Cd40–/– nodose neurons were overlapping 
and virtually identical (not shown), suggesting that target 
innervation by TH-positive nodose ganglion neurons is un-
likely to affect our analysis.
The mice were studied using iDISCO at P10, by which 
time the sympathetic innervation of these organs has be-
come well established. The representative images shown in 
Figure 7a–c show that the spleen, kidney, and stomach were 
each more densely innervated in Cd40–/– mice compared 
with Cd40+/+ mice. Quantification of a standardized region 
of each organ performed blind showed that the innervation 
density of each organ was significantly higher in Cd40–/– 
mice compared with Cd40+/+ littermates (Figure  7d–f). In 
all organs, the innervation density of these organs in Cd40± 
mice was intermediate between that of Cd40–/– and Cd40+/+ 
littermates; however, only in the kidney was innervation den-
sity of Cd40± mice significantly greater than that of Cd40+/+ 
littermates. These in vivo observations suggest that CD40 is a 
physiologically relevant regulator of PVG target innervation. 
These observations are consistent with our in vitro data and 
suggest that CD40 functions as a negative regulator of PVG 
target innervation.
2.8 | NGF mRNA levels in PVG and SCG 
target tissues
We have shown that Cd40–/– mice have reduced sympathetic 
innervation in only a subset of SCG targets: those that ex-
press a very low level of NGF, whereas those that have a 
high level of NGF are unaffected (McWilliams et al., 2015). 
To assess the relative level of NGF synthesis in PVG targets 
and compare this with different SCG targets we measured the 
relative levels of NGF mRNA in different tissues at P10 rela-
tive to reference mRNAs encoding housekeeping proteins 
(glyceraldehyde phosphate dehydrogenase, succinate dehy-
drogenase, and hypoxanthine phosphoribosyltransferase-1). 
F I G U R E  6  Modulation of NGF-promoted axon growth from PVG and SCG neurons by a CD40L reverse signaling mechanism. Bar charts of 
total axon lengths in the arbors of PVG (a) and SCG (b) neurons of P0 Cd40+/+ and Cd40–/– littermates grown for 24 hr with either 1 ng/ml of NGF 
alone or NGF plus either 1 μg/ml of Fc, 1 μg/ml of CD40-Fc or 1 μg/ml of CD40L. Mean ± SEM data of >150 neurons per condition combined 
from three experiments of each type. *p < .05, one way ANOVA Kruskal–Wallis with Dunn's post hoc
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In addition to PVG targets (spleen, stomach, and kidney), we 
measured the level of NGF mRNA in two SCG targets: the 
thymus which expresses a very low level of NGF and whose 
innervation is significantly reduced in Cd40–/– mice and the 
submandibular salivary gland (SMG) which expresses a very 
high level of NGF and whose innervation is unaffected in 
Cd40–/– mice (McWilliams et al., 2015). Figure 8 shows that 
the level of NGF mRNA was substantially higher in the SMG 
than in the thymus (about 130-fold higher) whereas the lev-
els of NGF mRNA in the spleen, stomach, and kidney were 
much higher than in the thymus (between 5- and 10-fold 
greater) but much lower than in the SMG. Our findings sug-
gest that the NGF mRNA level in PVG targets is intermedi-
ate between tissues whose innervation by the SCG is either 
reduced or unaffected by the deletion of the Cd40 gene.
3 |  DISCUSSION
Our analysis of mice with a null mutation in the Cd40 gene 
has demonstrated that CD40 is a physiological regulator of 
the establishment of the sympathetic innervation of organs 
innervated by PVG. We show that all PVG target organs 
examined in Cd40–/– mice are hyperinnervated compared 
F I G U R E  7  Hyperinnervation of PVG 
target organs in mice with a null mutation 
in the Cd40 gene. Representative images 
of iDISCO preparations of the spleen (a), 
kidney (b) and stomach (c) of P10 Cd40+/+, 
Cd40±, and Cd40–/– littermates stained 
for TH. Scale bars, 100 μm. Bar charts of 
innervation density quantified in the spleen 
(d), kidney (e) and, stomach (f) in at least 
six mice of each genotype normalized 
to 100 in Cd40+/+ mice. ***p < .001, 
**p < .01, and *p < .05, one way ANOVA 
with Dunnett's post hoc
F I G U R E  8  NGF mRNA levels in PVG and SCG targets. Bar 
chart of the levels of Ngf mRNA relative to reference mRNAs in the 
thymus, submandibular salivary gland (SMG), spleen, stomach, and 
kidney dissected from P10 wild-type mice
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with those in wild-type mice. This is in marked contrast to 
the subset of SCG targets that have been shown to be hy-
poinnervated in Cd40–/– mice (McWilliams et al., 2015). 
This difference in the sympathetic innervation of PVG and 
SCG targets in CD40-deficient mice is consistent with our 
in vitro studies, which demonstrate that CD40 has opposite 
effects on NGF-promoted axon growth from PVG and SCG 
neurons. Whereas the axon arbors of PVG neurons cultured 
from CD40-deficient mice are significantly longer and more 
branched than wild-type PVG neurons, the axon arbors of 
SCG neurons cultured from CD40-deficient neonates are sig-
nificantly shorter and less branched than wild-type SCG neu-
rons. This suggests that CD40 reduces NGF-promoted axon 
growth from PVG neurons, whereas CD40 enhances NGF-
promoted axon growth from SCG neurons. Interestingly, 
PVG neurons are slightly less responsive to NGF than SCG 
neurons at all ages studied. The reason for this small consist-
ent difference is unclear. This difference does not affect our 
conclusion that CD40 has opposite roles in the regulation of 
NGF-promoted axon growth in PVG and SCG neurons.
The co-expression of CD40 and CD40L in both PVG and 
SCG neurons and our demonstration that the NGF-promoted 
axon growth phenotype of both CD40-deficient PVG and 
SCG neurons is rescued by CD40-Fc, but not by CD40L, 
suggests that CD40 affects axon growth by participating in 
an autocrine CD40L reverse signaling loop in both kinds of 
sympathetic neurons. Several other members of the TNF and 
TNFR superfamilies modulate axon growth by acting via au-
tocrine signaling loops (Gavalda, Gutierrez, & Davies, 2009; 
Howard et al., 2018; Kisiswa et al., 2013; O'Keeffe et al., 
2008). It is only by experimentally breaking such loops, by 
either knocking out one of the participants of the signaling 
loop or by function-blocking antibodies that interfere with 
binding of the participants, that the importance of these loops 
has been revealed.
In addition to regulating axon growth by participating 
in an autocrine CD40L reverse signaling loop in both PVG 
and SCG neurons, CD40 displays several other similarities 
of axon growth regulation in both of these populations of 
sympathetic neurons. First, it regulates axon growth during 
the same brief perinatal window of development in PVG 
and SCG neurons, a stage after the neurons have become 
dependent on NGF for survival and when their axons are 
ramifying extensively within their targets. Other TNF/TNFR 
superfamily members that regulate axon growth usually act 
over similar late developmental windows (Gavalda et al., 
2009; Gutierrez et al., 2013; Howard et al., 2018; Kisiswa 
et al., 2013; O'Keeffe et al., 2008). Second, CD40L reverse 
signaling does not affect axon growth on its own in either 
PVG or SCG neurons, rather it modulates the response of 
both kinds of neurons to the axon growth-promoting effects 
of the neurotrophin NGF. This is similar to several other 
TNF/TNFR superfamily members that also modulate the 
axon growth-promoting actions of neurotrophins, either 
positively or negatively, but do not affect axon growth alone 
(Gutierrez et al., 2013; Howard et al., 2018; O'Keeffe et al., 
2008; Wheeler et al., 2014). Third, CD40L reverse signal-
ing has no effect on the survival of PVG and SCG neurons, 
either alone or in the presence of NGF. CD40L reverse sig-
naling only modulates the axon-promoting actions of NGF, 
not the survival-promoting actions of NGF. In this respect, 
CD40L reverse signaling in PVG and SCG neurons is similar 
to other TNF and TNFR superfamily members that regulate 
axon growth. These proteins, unlike neurotrophins, have no 
effect on neuronal survival but selectively modulate the axon 
growth-promoting actions of neurotrophins (Gavalda et al., 
2009; Gutierrez et al., 2013; Howard et al., 2018; Kisiswa 
et al., 2013; O'Keeffe et al., 2008).
It is striking that CD40L reverse signaling has opposite 
effects on NGF-promoted axon growth from different pop-
ulations of the same class of neurons. In this respect, there 
is a parallel with the opposite effects of CD40L reverse sig-
naling on dendrite growth from different kinds of CNS neu-
rons. Whereas CD40L reverse signaling is a physiological 
enhancer of dendrite growth and branching from hippocampal 
pyramidal neurons, it is a physiological repressor of dendrite 
growth and branching from striatal medium spiny neurons 
(Carriba & Davies, 2017). However, it is not known whether 
CD40L reverse signaling modulates the actions of a putative 
dendrite growth-promoting factor or whether it modulates an 
intrinsic program of dendrite growth in these different CNS 
neurons. In future work, it will be informative to elucidate 
the molecular mechanisms by which CD40L reverse signal-
ing exerts diametrically opposite effects on neural process 
growth from different neurons.
Another aspect that our work on CD40L reverse sig-
naling in developing sympathetic neurons has begun to 
clarify is how the level of NGF itself regulates the opera-
tion of the CD40–CD40L signaling loop. We have shown 
that NGF negatively regulates Cd40 mRNA expression 
in both PVG and SCG neurons, which, in turn, decreases 
the influence of the CD40–CD40L signaling loop on axon 
growth and target innervation density. SCG neurons are 
an order of magnitude more sensitive to the negative reg-
ulation of CD40 expression by NGF than PVG neurons. 
The in vivo consequence of this is that the innervation of 
SCG targets expressing high levels of NGF is not at all 
affected in Cd40–/– mice (McWilliams et al., 2015). The 
inference of this observation is that the growth-promoting 
CD40–CD40L signaling loop is switched off in the SCG 
neurons that innervate these targets. Defective innerva-
tion in Cd40–/– mice is only observed in SCG targets that 
express vanishingly low levels of NGF (McWilliams et al., 
2015), presumably because there is insufficient NGF to 
switch off the growth-promoting CD40–CD40L signaling 
loop in the neurons that innervate these targets in vivo. The 
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PVG targets we studied express levels of NGF mRNA that 
are intermediate between the very high and very low levels 
of NGF mRNA in the SCG targets we previously studied. 
The level of NGF synthesis in these PVG targets is insuf-
ficient to repress the CD40–CD40L signaling loop in PVG 
neurons because there is a hyperinnervation phenotype 
in these targets in Cd40–/– mice. Nonetheless, it is likely 
that the negative regulation of CD40–CD40L signaling by 
target-derived NGF in PVG neurons may have subtle re-
gional consequences for the innervation of different targets 
depending on the level of NGF they synthesize. In future 
work, it will be interesting to explore this relationship in-
depth by examining the sympathetic innervation of a vari-
ety of PVG targets that express different levels of NGF in 
Cd40–/– mice.
Because of the difficulties of culturing PVG neurons, 
there has only been one previous comparative study of the 
regulation of axon growth from prevertebral and paraver-
tebral sympathetic neurons (Erice et al., 2019). Whereas 
TNFR1-activated TNF-mediated reverse signaling in-
creases NGF-promoted axon growth from SCG neurons, 
it does not affect PVG axon growth. Accordingly, SCG 
targets, but not PVG targets, are hypoinnervated in mice 
that lack either TNFR1 or TNF. These findings together 
with our current observations are beginning to reveal un-
suspected physiologically relevant differences in the regu-
lation of axon growth from prevertebral and paravertebral 
neurons. This raises the question of whether differences 
in axon growth regulation between SCG and PVG neu-
rons apply to other growth factors. Comparative studies 
of the response of SCG and PVG neurons to factors that 
have been shown to affect SCG axon growth may provide 
a clearer understanding of how the sympathetic innerva-
tion of different tissues is established and refined during 
development.
In addition to the widespread influence of CD40L-
mediated CD40-activated reverse signaling on axon and 
dendrite growth, CD40L-activated CD40-mediated forward 
signaling has recently been shown to be a physiological 
regulator of axon growth from developing sensory neurons 
(Howard et al., 2019). In contrast to the late developmen-
tal window over which CD40L reverse signaling and other 
members of TNF/TNFR superfamilies influence the growth 
of neural processes, CD40 forward signaling acts very early 
and transiently on sensory axons when they are growing to 
their targets. In addition to acting by an autocrine mechanism, 
there is evidence for a significant target-derived component 
to the action of CD40 forward signaling on early sensory neu-
rons (Howard et al., 2019).
Our current study adds to the growing body of work 
showing that CD40 and CD40L play an extraordinarily 
wide physiological role in regulating the growth of neu-
ral processes in the developing nervous system. CD40 and 
CD40L influence axon and dendrite growth from several 
kinds of PNS and CNS neurons at different key stages of de-
velopment, acting by reverse and forward signaling mecha-
nisms. The unique feature revealed by our current study is 
the surprising finding that CD40–CD40L can have marked 
and diametrically opposite effects on different populations 
of the same class of neurons and the innervation of their 
target tissues. While all studies of the influence of CD40L 
and CD40 signaling have focused on normal neural devel-
opment, it will be interesting to explore the possibility that 
CD40L and CD40 play a role modulating the morphology 
of neural processes in the mature nervous system. It will be 
particularly interesting to explore whether CD40L-CD40 
signaling participates in regeneration following neural in-
jury and disease, especially given the well-established role 
of CD40L-CD40 signaling in the immune system and in 
autoimmune disease (Calderhead, Kosaka, Manning, & 
Noelle, 2000; Peters et al., 2009).
4 |  MATERIALS AND METHODS
4.1 | Mice
Mice were housed in a 12  hr light–dark cycle with access 
to food and water ad libitum. Breeding was approved by 
the Cardiff University Ethical Review Board and was per-
formed within the guidelines of the Home Office Animals 
(Scientific Procedures) Act, 1986. Cd40 null mutant mice on 
a C57BL6/J background were purchased from The Jackson 
Laboratory (Maine, USA). These mice were back-crossed 
into a CD1 background. Cd40± mice were crossed to gener-
ate Cd40–/–, Cd40±, and Cd40+/+ mice.
4.2 | Immunocytochemistry
The cultures were fixed in 4% paraformaldehyde (PFA) for 
20  min and were washed with phosphate-buffered saline 
(PBS) before blocking nonspecific binding and permeabiliz-
ing the cells with 5% bovine serum albumin (BSA) and 5% 
donkey serum plus 0.1% Triton X-100 (Sigma, Dorset, UK) 
in PBS for 1  hr at room temperature. Neurons were incu-
bated overnight with the primary antibody in 1% blocking 
solution at 4°C. After washing with PBS, the cultures were 
incubated with the appropriate secondary antibody. The pri-
mary antibodies were: anti-class III β tubulin (1:500, Abcam, 
ab41489), anti-CD40 (1:500, MA5-15535, Invitrogen), and 
anti-CD40L (1:200, Abcam, ab2391). Secondary antibod-
ies were Alexa Fluor conjugated anti-immunoglobulin from 
Thermo Fisher Scientific used at 1:500 (donkey anti-rabbit 
IgG Alexa Fluor 488, A32790, goat anti-chicken Alexa 
Fluor 594, A11042 and goat anti-mouse Alexa Fluor 488, 
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A11001). Images were obtained using a Zeiss LSM 710 con-
focal microscope.
4.3 | Dissociated neuron culture
Dissected paravertebral SCG and prevertebral coeliac and 
superior mesenteric ganglia (PVG) were freed of adherent 
connective tissue using tungsten needles and were trypsi-
nized and plated at very low density (~200 neurons per 
dish/well) in poly-ornithine and laminin-coated 35 mm tis-
sue culture dishes (Greiner, Gloucestershire, UK) or 4-well 
dishes (Starlab, Milton Keynes, UK) in serum-free Hams 
F14 medium (Davies et al., 1993) supplemented with 0.25% 
Albumax I (Invitrogen, Paisley, UK). Neurons were grown 
with NGF, Fc control protein, recombinant CD40-Fc, CD40L 
(R&D Systems), and caspase inhibitor III (Boc-D-FMK) 
(Merck) at the concentrations indicated. Analysis of the size 
and complexity of neurite arbors was carried out in 35 mm 
dishes 24  hr after plating. The neurite arbors were labeled 
by incubating the neurons with the fluorescent vital dye 
calcein-AM (1:1,000, Invitrogen, Paisley, UK) at the end of 
the experiment. Images of neurite arbors were acquired by 
fluorescence microscopy and analyzed to obtain the Sholl 
profiles (Gutierrez & Davies, 2007).
4.4 | Quantification of sympathetic 
innervation
Several organs that receive sympathetic innervation pre-
dominantly from PVG (stomach, spleen, and kidney) were 
dissected and processed for the visualization of sympathetic 
fibers by tyrosine hydroxylase (TH) staining using the im-
munolabeling-enabled three-dimensional imaging of solvent-
cleared organs (iDISCO) technique. The experiments were 
carried out on tissues from P10 pups. Batches of tissue from 
littermates of all three genotypes were processed at the same 
time to ensure they were stained in an identical manner. TH-
positive fibers were fluorescently labeled using anti-TH an-
tibody (1:200 dilution of antibody AB152, Chemicon) and 
secondary antibody 1:300 (donkey anti-rabbit IgG Alexa 
Fluor 594, A21207, Thermo Fisher Scientific). Using a 3-D 
printed compartment, the stomach, spleen, and kidney were 
imaged in their entirety using confocal microscopy (Zeiss 
Axio Z2 Imager) and z-stacks were constructed. The same 
anatomical regions from each organ set were analyzed to 
keep the quantification consistent. The kidney samples were 
each analyzed entirely. The spleen samples curled up from 
the anterior and posterior ends, so to exclude variability that 
imaging the small curled regions, these parts were excluded, 
keeping the analyzed surface area the same in all spleen sam-
ples. The stomach has milk at this stage of the development 
which causes an uneven surface near the greater curvature for 
standardized quantification. To provide the same measure-
ment criteria for the analysis, we chose the most intensely 
innervated regions: the lesser curvature, cardia, fundus, and 
upper half of the body. Fiji-Image J was used for the semi- 
automated quantification of TH-immunoreactivity as a meas-
ure of sympathetic target organ innervation density. Images 
were converted to greyscale and the Feature Extraction 
(FeatureJ Hessian) tool was employed using the smallest 
eigenvalue of Hessian tensor with the smoothing scale set to 
1.5. To ensure consistent analysis across all conditions, multi-
ple images from all mice were initially analyzed to generate a 
uniform threshold value, which was applied to every image of 
the same organ analyzed followed by a user-defined macro to 
provide a quantitative measurement of TH-immunoreactivity 
within each target organ. The data are expressed as a percent-
age of the mean of the wild-type data. All imaging and quan-
tification were performed blind.
4.5 | RT-qPCR
The levels of Ngf and Cd40 mRNAs were quantified by real-
time PCR relative to a geometric mean of mRNAs for the 
housekeeping enzymes glyceraldehyde phosphate dehydroge-
nase (Gapdh), succinate dehydrogenase (Sdha), and hypox-
anthine phosphoribosyltransferase-1 (Hprt1). Total RNA was 
extracted from dissected sympathetic target fields or cultured 
sympathetic neurons using the RNeasy lipid mini extraction kit 
(Qiagen, Crawley, UK) and 5 μl was reverse transcribed for 
1 hr at 45°C using the AffinityScript kit (Agilent, Berkshire, 
UK) in a 25  μl reaction according to the manufacturer's in-
structions. About 2 μl of cDNA was amplified in a 20 μl re-
action volume using Brilliant III ultrafast qPCR master mix 
reagents (Agilent). PCR products were detected using dual-
labeled (FAM/BHQ1) hybridization probes specific to each 
of the cDNAs (MWG/Eurofins, Ebersberg, Germany). The 
PCR primers were: Ngf forward: 5ʹ-AAA CGG AGA CTC 
CAC TCA CC-3ʹ and reverse: 5ʹ-GTC CTG TTG AAA GGG 
ATT GTA CC-3ʹ; Cd40 forward: 5ʹ-CTT TGG AGT TAT 
GGA GAT G-3ʹ and reverse: 5ʹ-ATG ACT GAT TGG AGA 
AGA-3ʹ; Gapdh forward: 5ʹ-GAG AAA CCT GCC AAG TAT 
G-3ʹ and reverse: 5ʹ-GGA GTT GCT GTT GAA GTC-3ʹ; Sdha 
forward: 5ʹ-GGA ACA CTC CAA AAA CAG-3ʹ and reverse: 
5ʹ-CCA CAG CAT CAA ATT CAT-3ʹ; Hprt1 forward: TTA 
AGC AGT ACA GCC CCA AAA TG and reverse: AAG TCT 
GGC CTG TAT CCA ACA C. Dual-labeled probes were: 
Ngf: 5ʹ-FAM-TGT TCA GCA CCC AGC CTC CAC CCA-
BHQ1-3ʹ; Cd40: 5ʹ-FAM-CCA CTG AGA CCA CTG ATA 
CCG-BHQ1-3ʹ; Gapdh: 5ʹ-FAM-AGA CAA CCT GGT CCT 
CAG TGT-BHQ1-3; Sdha: 5′-FAM-CCT GCG GCT TTC 
ACT TCT CT-BHQ1-3ʹ, Hrpt1: FAM-TCG AGA GGT CCT 
TTT CAC CAG CAA G-BHQ1. Forward and reverse primers 
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were used at a concentration of 150 nM and dual-labeled probes 
were used at a concentration of 300 nM. PCR was performed 
using the Mx3000P platform (Agilent) using the following con-
ditions: 45 cycles of 95°C for 10 s and 60°C for 35 s. Standard 
curves were generated for each cDNA for every real-time PCR 
run, by serial fivefold dilutions of reverse-transcribed mouse 
adult spleen total RNA (Zyagen, San Diego, USA). Relative 
mRNA levels were quantified in four separate sets of dissected 
tissues and cultured cells for each experiment. Primer and probe 
sequences were designed using Beacon Designer software 
(Premier Biosoft, Palo Alto, USA).
4.6 | Statistics
Statistical comparisons for normally distributed data were 
performed by t-test or one-way ANOVA followed by 
Dunnett's post hoc test. Non-parametric Mann–Whitney test 
or one-way ANOVA Kruskal–Wallis test followed by the 
Dunn's multiple post hoc test were performed for the data 
that were not normally distributed.
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